GemPharmatech, a Chinese company that provides genetically-modified mice for use in drug tests, has raised RMB400 million ($58.6 million) Series B led by GL Ventures, the VC arm of Hillhouse Capital.
Yunfeng Capital, Morgan Stanley Private Equity Asia, Sequoia Capital China and TF Capital also took part in the round. The proceeds will go toward the construction of a headquarters in Nanjing, the development...
JD Health, the healthcare unit of Chinese e-commerce giant JD.com, has filed for Hong Kong IPO. The company’s backers include Hillhouse Capital, CPE, CICC Capital, and Baring Private Equity Asia.
General Atlantic has become the third global GP to double down on Reliance Industries’ plans to reinvent digital consumer services in India, following its earlier commitment to Jio Platforms with an investment in the conglomerate’s retail unit.
Green Monday, the Hong Kong plant-based food distributor behind the Green Common retail chain and OmniPork alternative meats, has raised its first institutional round of funding.
AVCJ's daily bulletin will not be published on October 1 or 2 due to consecutive public holidays in Hong Kong.